Medicaid’s Most Costly Outpatient Drugs
(By Katherine Young, Robin Rudowitz, Rachel Garfield, and Marybeth Musumeci for Kaiser Family Foundation) The launch of several expensive hepatitis
Read More
Part D/Prescription Drugs
Targrisso: Second-line Treatment Met Its Goal
AstraZeneca said its experimental lung cancer drug Tagrisso met its main goal as a second-line therapy in a late-stage drug
Read MoreIt All Comes Down to Money
In the multibillion-dollar legal battle between Anthem Inc. and Express Scripts it all centers on the high drug prices with
Read MoreFraud Concerns Emerge As Compounding Drug Sales Skyrocket
(By Julie Appleby for Kaiser Health News) Government spending on “compounded” drugs that are handmade by retail pharmacists has skyrocketed,
Read MoreSynthetic marijuana drives a growing number of overdoses nationwide
(By Lindzi Wessel for STAT) Just two days after a suspected synthetic marijuana poisoning in New York City sent 33
Read MoreInsurers Can Reduce Drug Prices, If Policymakers Let Them
(By David Howard for Health Affairs Blog, July 14, 2016 Whilst decrying rapid increases in drug spending and prices, elected
Read MoreDespite Opioid Concerns, Seniors Often Exit The Hospital With Prescription: Study
(By Michelle Andrews for Kaiser Health News) It’s a common scenario: Someone checks into a hospital for surgery or an
Read MoreSenate sends first major opioids legislation to Obama’s desk
(By Dylan Scott for STAT) WASHINGTON — The first major legislation to address the growing crisis of opioid addiction is
Read MoreLISTEN: The superbugs are winning the battle against us
(By Meg Tirrell and Luke Timmerman for STAT) This is totally sleeper phase right now … you want to get
Read MoreDo all Melanoma respond to Immunotherapy?
In a study published this week in the New England Journal of Medicine, which was funded by the National Cancer
Read More